Testing effectiveness (Phase 2)WithdrawnNCT03880279What this trial is testingAutologous TAC T Cells Targeting CD19 in R/R Large B-Cell LymphomaWho this might be right forLymphoma, B-Cell Triumvira Immunologics, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)UnknownNCT03776279What this trial is testingLiposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell LymphomaWho this might be right forRelapsed or Refractory Peripheral T-cell and NK/T-cell Lymphoma CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 106
Testing effectiveness (Phase 2)Study completedNCT04477486What this trial is testingStudy to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma (MCL) AbbVie 13
Testing effectiveness (Phase 2)UnknownNCT05816746What this trial is testingDecitabine and Anti-PD-1 in R/R DLBCLWho this might be right forDiffuse Large B Cell LymphomaRelapse/RecurrenceExtranodal Extension+1 more Chinese PLA General Hospital 20
Very early researchLooking for participantsNCT07429461What this trial is testingClinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic LeukemiaWho this might be right forB-Cell Acute Lymphoblastic Leukemia Zhejiang University 16
Not applicableStudy completedNCT04872413What this trial is testingInterrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH TrialWho this might be right forRecurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT06941688What this trial is testingEvaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell LymphomaWho this might be right forPeripheral T-cell Lymphoma (PTCL) Seoul National University Hospital 17
Early research (Phase 1)UnknownNCT05453669What this trial is testingClinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHLWho this might be right forB-cell Non-Hodgkin's Lymphoma Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Early research (Phase 1)Active Not RecruitingNCT01695941What this trial is testingAlisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin LymphomaWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Mantle Cell LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+1 more National Cancer Institute (NCI) 24
Early research (Phase 1)Looking for participantsNCT06927466What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.Who this might be right forRelapsed or Refractory B-cell Acute Lymphoblastic Leukemia Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. 33
Testing effectiveness (Phase 2)Ended earlyNCT03808610What this trial is testingLow-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic LeukemiaWho this might be right forRecurrent B Acute Lymphoblastic LeukemiaRecurrent T Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)UnknownNCT04052659What this trial is testingSintilimab (IBI308) in Combination With Chidamide and Azacitidine in Refractory or Relapsed PTCLWho this might be right forPeripheral T-cell Lymphoma Peking University 30
Testing effectiveness (Phase 2)UnknownNCT02685670What this trial is testingCompetitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/LymphomaWho this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+19 more The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20
Testing effectiveness (Phase 2)UnknownNCT03321123What this trial is testingMB-CART19.1 in Patients With R/R ALLWho this might be right forPrecursor B-Lymphoblastic Lymphoma/Leukaemia Refractory Shanghai Children's Medical Center 10
Early research (Phase 1)Active Not RecruitingNCT05618327What this trial is testingPhase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forRelapsed/Refractory B-cell Non-Hodgkin's Lymphoma Shanghai Junshi Bioscience Co., Ltd. 104
Early research (Phase 1)Study completedNCT01321346What this trial is testingPanobinostat In Children With Refractory Hematologic MalignanciesWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more Therapeutic Advances in Childhood Leukemia Consortium 30
Large-scale testing (Phase 3)Study completedNCT00799461What this trial is testingInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Early research (Phase 1)UnknownNCT03221348What this trial is testingA Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular LymphomaWho this might be right forFollicular Lymphoma Cho Pharma Inc. 24
Early research (Phase 1)Not Yet RecruitingNCT06318884What this trial is testingA First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma, B-cell Sinocelltech Ltd. 76